Aerie Pharmaceuticals, Inc

(NASDAQ:AERI)

Latest On Aerie Pharmaceuticals, Inc (AERI):

Date/Time Type Description Signal Details
2022-11-16 07:16 ESTNewsAerie Pharmaceuticals last day of trading expected Nov. 18 as part of Alcon mergerN/A
2022-11-03 22:31 ESTNewsAerie Pharmaceuticals Non-GAAP EPS of -$0.27 beats by $0.16, revenue of $36.1M beats by $0.8MN/A
2022-08-23 23:47 ESTNewsAlcon to acquire Aerie Pharmaceuticals at ~$770M, enhancing its ophthalmic pharmaceutical portfolioN/A
2022-08-15 10:16 ESTNewsAerie Pharmaceuticals grants 16.9K stock optionsN/A
2022-08-07 19:01 ESTNewsAerie Pharmaceuticals, Inc.'s (AERI) CEO Raj Kannan on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-05 14:01 ESTNewsAerie Pharma rises 14% after Q2 result beat on higher glaucoma franchise salesN/A
2022-08-04 22:46 ESTNewsAerie Pharmaceuticals Non-GAAP EPS of -$0.32 beats by $0.23, revenue of $33.3M beats by $0.71MN/A
2022-06-10 10:01 ESTNewsAerie Pharmaceuticals Q2 2022 Earnings PreviewN/A
2022-05-25 11:21 ESTNewsAerie Pharmaceuticals begins dosing in late-stage study of AR-15512 for dry eye diseaseN/A
2022-05-07 16:01 ESTNewsAerie Pharmaceuticals' (AERI) CEO Raj Kannan on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-05 20:16 ESTNewsAerie Pharmaceuticals Non-GAAP EPS of -$0.66 misses by $0.01, revenue of $29.83M misses by $0.07MN/A
2022-05-04 21:30 ESTNewsAerie Pharmaceuticals Q1 consensus EPS, revenue estimates upN/A
2022-03-18 10:32 ESTNewsAerie Pharmaceuticals appoints new finance chiefN/A
2022-02-25 21:46 ESTNewsAerie swings to profits in Q4 thanks to licensing deal with SantenN/A
2022-02-25 03:46 ESTNewsAerie Pharmaceuticals Non-GAAP EPS of $1.09 beats by $1.77, revenue of $114.7M beats by $83.54MN/A
2022-02-25 03:45 ESTNewsAerie Pharmaceuticals, Inc. (AERI) CEO Raj Kannan on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-24 08:01 ESTNewsAerie Pharmaceuticals Q4 2021 Earnings PreviewN/A
2022-02-24 08:00 ESTNewsAerie Pharmaceuticals appoints Gary Sternberg as medical chiefN/A
2021-12-16 21:49 ESTNewsAerie Pharmaceuticals appoints new CEON/A
2021-12-16 21:49 ESTNewsRaj Kannan joins Aerie pharmaceuticals as CEON/A
2021-12-08 01:33 ESTNewsAerie inks licensing deal for Rhopressa and Rocklatan in Europe and several other regionsN/A
2021-11-07 08:45 ESTNewsAerie Pharmaceuticals' (AERI) Management on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-05 00:16 ESTNewsAerie Pharmaceuticals EPS misses by $0.10, beats on revenueN/A
2021-11-04 03:01 ESTNewsAerie Pharmaceuticals Q3 2021 Earnings PreviewN/A
2021-10-23 02:33 ESTNewsWarning: AERI is at high risk of performing badlyN/A
2021-10-20 01:46 ESTNewsAerie Pharmaceuticals interim CFO resignsN/A
2021-10-12 19:33 ESTNewsAerie Pharma jumps 10% on positive netarsudil data in late-stage ocular hypertension studyN/A
2021-10-07 03:43 ESTNewsAERI is at high risk of performing badlyN/A
2021-09-27 11:54 ESTNewsWarning: AERI has been downgraded to Very BearishN/A
2021-09-22 20:14 ESTNewsAerie Pharmaceuticals (AERI) Investor Presentation - SlideshowN/A
2021-09-22 20:08 ESTNewsAerie Pharmaceuticals' CEO to step down amid Wall Street concerns over eye drug trial resultsN/A
2021-09-21 07:01 ESTNewsAerie Pharmaceuticals appoints interim executive chairmanN/A
2021-09-20 05:00 ESTNewsWarning: AERI has been downgraded to Very Bearish.N/A
2021-09-16 14:02 ESTNewsAerie reaches a 10 month low after trial setback while analysts cheer resultsN/A
2021-09-15 18:00 ESTNewsLAUR, LPTX, AERI and TWKS among after hours moversN/A
2021-09-15 17:01 ESTNewsAerie Pharma slips after announcing eye disease trial failed to meet primary endpointsN/A
2021-08-05 21:09 ESTNewsAerie Pharmaceuticals' (AERI) CEO Vince Anido on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-04 22:47 ESTNewsAerie Pharmaceuticals EPS misses by $0.18, beats on revenueN/A
2021-07-20 17:46 ESTNewsAerie Pharma completes enrollment in first Phase 3 trial of netarsudil in JapanN/A
2021-05-06 06:32 ESTNewsAerie Pharmaceuticals EPS misses by $0.04, misses on revenueN/A
2021-05-06 06:31 ESTNewsAerie Pharmaceuticals, Inc. (AERI) CEO Vince Anido on Q1 2021 Results - Earnings Call TranscriptN/A
2021-03-02 07:17 ESTNewsAerie Pharmaceuticals (AERI) Axitinib Implant (AR-14034) Overview - SlideshowN/A
2021-03-01 07:03 ESTEarnings EstimateAn EPS average of -$0.61 is estimated for the quarter ending on June 30, 2021.Buy
2021-03-01 07:03 ESTEarnings EstimateAn EPS average of -$1.09 is estimated for the 2022 year.Sell
2021-03-01 07:03 ESTAnalyst RatingThe Analyst Target Price has increased from $26.83 to $27.25.Buy
2021-02-26 14:18 ESTNewsAerie Pharmaceuticals, Inc. (AERI) CEO Vince Anido on Q4 2020 Results - Earnings Call TranscriptN/A
2021-02-26 14:16 ESTNewsAerie Pharmaceuticals shares rise after Q4 topline beatN/A
2021-02-26 07:02 ESTFinancialsCompany financials have been released.Neutral
2021-02-05 07:03 ESTAnalyst RatingThe Analyst Target Price has increased from $26.67 to $26.83.Buy
2021-01-18 07:02 ESTAnalyst RatingThe Analyst Target Price has decreased from $26.75 to $26.67.Neutral

About Aerie Pharmaceuticals, Inc (AERI):

Aerie Pharmaceuticals, Inc., an ophthalmic pharmaceutical company, focuses on the discovery, development, and commercialization of first-in-class therapies for the treatment of glaucoma, ocular surface, and retinal diseases in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension; and Rocklatan, a once-daily fixed-dose combination of Rhopressa and latanopros to reduce IOP to treat patients with open-angle glaucoma. The company is also developing AR-15512 to treat signs and symptoms of dry eye; and AR-1105, AR-13503 SR, and AR-14034 SR sustained-release implants focused on retinal diseases. It has a collaborative research, development, and licensing agreement with DSM. Aerie Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Durham, North Carolina.

AERI Quotes by TradingView

See Advanced Chart

General

  • Name Aerie Pharmaceuticals, Inc
  • Symbol AERI
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-Specialty & Generic
  • Full Time Employees 365
  • Fiscal Year EndDecember
  • IPO Date2013-10-25
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.aeriepharma.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 11.09
  • Price/Book (Most Recent Quarter) 39.31
  • Enterprise Value Revenue 11.15
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.35
  • Next Year EPS Estimate -$1.30
  • Next Quarter EPS Estimate -$0.65
  • Profit Margin -220%
  • Operating Margin -187%
  • Return on Assets -23%
  • Return on Equity -192%
  • Revenue 83.14 million
  • Earnings Per Share -$5.17
  • Revenue Per Share $1.81
  • Gross Profit 55.5 million
  • Quarterly Earnings Growth 0.1%
View More

Highlights

  • Market Capitalization 920.04 million
  • EBITDA -199219008
  • Analyst Target Price $27.25
  • Book Value Per Share $0.51
View More

Share Statistics

  • Shares Outstanding 46.92 million
  • Shares Float 45.8 million
  • % Held by Insiders 211%
  • % Held by Institutions 109.26%
  • Shares Short 7.32 million
  • Shares Short Prior Month 7.02 million
  • Short Ratio 9.63
  • Short % of Float 21%
  • Short % of Shares Outstanding 16%
View More

Technicals

  • Beta 0.58
  • 52 Week High $21.3
  • 52 Week Low $9.01
  • 50 Day Moving Average 18
  • 200 Day Moving Average 13.82
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Aerie Pharmaceuticals, Inc (AERI) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Aerie Pharmaceuticals, Inc (AERI) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-26$N/A-$0.80-$0.73-8.49%
2020-09-302020-11-06$N/A-$0.65-$0.8019.2%
2020-06-302020-08-07$N/A-$0.83-$0.80-3.58%
2020-03-312020-05-06$20.34 million-$0.84-$0.78-8.39%
2019-12-312020-02-20$24.66 million-$0.96-$0.77-24.84%
2019-09-302019-11-06$18.54 million-$0.86-$0.80-7.66%
2019-06-302019-08-07$15.84 million-$0.80-$0.889.48%
2019-03-312019-05-07$10.85 million-$0.78-$0.9517.51%
2018-12-312019-02-25$14.46 million-$0.92-$0.87-5.75%
2018-09-302018-11-06$7.3 million-$1.73-$1.38-25.02%
2018-06-302018-08-08$2.42 million-$1.14-$0.98-16.07%
2018-03-312018-05-08$N/A-$0.83-$0.874.11%
2017-12-312018-02-28$N/A-$1.38-$1.21-13.84%
2017-09-302017-11-08$N/A-$0.71-$0.63-12.45%
2017-06-302017-08-01$N/A-$0.63-$0.62-2.32%
2017-03-312017-05-02$N/A-$0.62-$0.689.4%
2016-12-312017-03-07$N/A-$0.72-$0.67-6.78%
2016-09-302016-11-02$N/A-$0.67-$0.66-1.3%
2016-06-302016-08-03$N/A-$0.72-$0.742.04%
2016-03-312016-05-02$N/A-$0.72-$0.65-10.21%
2015-12-312016-03-01$N/A-$0.64-$0.7311.81%
2015-09-302015-11-03$N/A-$0.56-$0.6615.15%
2015-06-302015-08-05$N/A-$0.59-$0.7015.71%
2015-03-312015-05-07$N/A-$0.59-$0.590%
2014-12-312015-03-02$N/A-$0.59-$0.46-28.26%
2014-09-302014-11-11$N/A-$0.44-$0.40-10%
2014-06-302014-08-06$N/A-$0.49-$0.34-44.12%
2014-03-312014-05-12$N/A-$0.28-$0.3520%
2013-12-312014-03-18$N/A-$0.45-$0.25-80%
2013-09-302013-12-05$N/A-$0.47

Aerie Pharmaceuticals, Inc (AERI) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Aerie Pharmaceuticals, Inc (AERI) Chart:

Aerie Pharmaceuticals, Inc (AERI) News:

Below you will find a list of latest news for Aerie Pharmaceuticals, Inc (AERI) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Aerie Pharmaceuticals, Inc (AERI) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest AERI Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST98$5.985
Jun 13, 2022 7:59 PM EST7$5.99
Jun 13, 2022 7:59 PM EST2$5.985
Jun 13, 2022 7:59 PM EST155$5.98
Jun 13, 2022 7:59 PM EST4$5.98

Aerie Pharmaceuticals, Inc (AERI) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-30SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1337553/000119380520000759/0001193805-20-000759-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1337553/000083423720008735/0000834237-20-008735-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1337553/000090221919000089/0000902219-19-000089-index.htm
2020-01-28SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1337553/000090221920000289/0000902219-20-000289-index.htm
2020-06-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1337553/000090221920000394/0000902219-20-000394-index.htm
2020-07-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1337553/000090221920000403/0000902219-20-000403-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1337553/000090266419000924/0000902664-19-000924-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1337553/000090266420000946/0000902664-20-000946-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1337553/000110465920017885/0001104659-20-017885-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1337553/000110465920020469/0001104659-20-020469-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1337553/000110465920021020/0001104659-20-021020-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1337553/000110465920021668/0001104659-20-021668-index.htm
2020-06-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1337553/000110465920072826/0001104659-20-072826-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1337553/000114420419007015/0001144204-19-007015-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1337553/000114420419007774/0001144204-19-007774-index.htm
2019-08-15SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1337553/000114420419040173/0001144204-19-040173-index.htm
2019-02-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519034713/0001193125-19-034713-index.htm
2019-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519071334/0001193125-19-071334-index.htm
2019-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519072285/0001193125-19-072285-index.htm
2019-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519072295/0001193125-19-072295-index.htm
2019-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519077416/0001193125-19-077416-index.htm
2019-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519077421/0001193125-19-077421-index.htm
2019-03-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519081417/0001193125-19-081417-index.htm
2019-04-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519099844/0001193125-19-099844-index.htm
2019-04-10DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1337553/000119312519102811/0001193125-19-102811-index.htm
2019-04-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519117873/0001193125-19-117873-index.htm
2019-05-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519130768/0001193125-19-130768-index.htm
2019-05-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519135814/0001193125-19-135814-index.htm
2019-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519145939/0001193125-19-145939-index.htm
2019-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519164594/0001193125-19-164594-index.htm
2019-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519171788/0001193125-19-171788-index.htm
2019-07-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519190876/0001193125-19-190876-index.htm
2019-07-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519199363/0001193125-19-199363-index.htm
2019-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519219443/0001193125-19-219443-index.htm
2019-08-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519224762/0001193125-19-224762-index.htm
2019-09-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519236654/0001193125-19-236654-index.htm
2019-09-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519238173/0001193125-19-238173-index.htm
2019-09-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519238177/0001193125-19-238177-index.htm
2019-09-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519241465/0001193125-19-241465-index.htm
2019-09-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519242162/0001193125-19-242162-index.htm
2019-09-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519242457/0001193125-19-242457-index.htm
2019-09-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519244953/0001193125-19-244953-index.htm
2019-09-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519248886/0001193125-19-248886-index.htm
2019-09-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519249968/0001193125-19-249968-index.htm
2019-10-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519260310/0001193125-19-260310-index.htm
2019-10-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519265805/0001193125-19-265805-index.htm
2019-10-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519273035/0001193125-19-273035-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519283989/0001193125-19-283989-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519285878/0001193125-19-285878-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519285901/0001193125-19-285901-index.htm
2019-11-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519293870/0001193125-19-293870-index.htm
2019-11-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519293874/0001193125-19-293874-index.htm
2019-11-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519296996/0001193125-19-296996-index.htm
2019-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519304758/0001193125-19-304758-index.htm
2019-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519304760/0001193125-19-304760-index.htm
2019-12-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312519313342/0001193125-19-313342-index.htm
2020-01-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312520000100/0001193125-20-000100-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312520005838/0001193125-20-005838-index.htm
2020-01-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312520010537/0001193125-20-010537-index.htm
2020-03-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312520057775/0001193125-20-057775-index.htm
2020-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312520076510/0001193125-20-076510-index.htm
2020-03-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312520091787/0001193125-20-091787-index.htm
2020-04-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312520102601/0001193125-20-102601-index.htm
2020-04-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312520105742/0001193125-20-105742-index.htm
2020-04-24DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1337553/000119312520119070/0001193125-20-119070-index.htm
2020-05-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312520139734/0001193125-20-139734-index.htm
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312520166098/0001193125-20-166098-index.htm
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312520166107/0001193125-20-166107-index.htm
2020-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312520169518/0001193125-20-169518-index.htm
2020-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312520170827/0001193125-20-170827-index.htm
2020-07-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312520189137/0001193125-20-189137-index.htm
2020-07-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312520199067/0001193125-20-199067-index.htm
2020-08-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312520216958/0001193125-20-216958-index.htm
2020-09-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312520241488/0001193125-20-241488-index.htm
2020-09-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312520245729/0001193125-20-245729-index.htm
2020-09-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312520245736/0001193125-20-245736-index.htm
2020-09-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312520252788/0001193125-20-252788-index.htm
2020-09-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312520257137/0001193125-20-257137-index.htm
2020-10-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312520264340/0001193125-20-264340-index.htm
2020-10-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312520279048/0001193125-20-279048-index.htm
2020-10-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000119312520280398/0001193125-20-280398-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1337553/000119380519000191/0001193805-19-000191-index.htm
2019-06-17SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1337553/000119380519000582/0001193805-19-000582-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1337553/000119380520000189/0001193805-20-000189-index.htm
2020-03-24SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1337553/000119380520000395/0001193805-20-000395-index.htm
2020-06-30SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1337553/000119380520000759/0001193805-20-000759-index.htm
2019-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919119009022/0001209191-19-009022-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919119011556/0001209191-19-011556-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919119013739/0001209191-19-013739-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919119013742/0001209191-19-013742-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919119013744/0001209191-19-013744-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919119013746/0001209191-19-013746-index.htm
2019-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919119024573/0001209191-19-024573-index.htm
2019-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919119024575/0001209191-19-024575-index.htm
2019-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919119024577/0001209191-19-024577-index.htm
2019-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919119031037/0001209191-19-031037-index.htm
2019-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919119031039/0001209191-19-031039-index.htm
2019-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919119031043/0001209191-19-031043-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919119032411/0001209191-19-032411-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919119032414/0001209191-19-032414-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919119032416/0001209191-19-032416-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919119032432/0001209191-19-032432-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919119032435/0001209191-19-032435-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919119032437/0001209191-19-032437-index.htm
2019-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919119032589/0001209191-19-032589-index.htm
2019-08-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919119046010/0001209191-19-046010-index.htm
2019-08-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919119046012/0001209191-19-046012-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919119046288/0001209191-19-046288-index.htm
2019-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919119046913/0001209191-19-046913-index.htm
2019-08-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919119047387/0001209191-19-047387-index.htm
2019-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919119048394/0001209191-19-048394-index.htm
2019-09-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919119048830/0001209191-19-048830-index.htm
2019-09-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919119048930/0001209191-19-048930-index.htm
2019-09-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919119048931/0001209191-19-048931-index.htm
2019-11-053/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919119055353/0001209191-19-055353-index.htm
2019-11-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919119055965/0001209191-19-055965-index.htm
2019-11-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919119056320/0001209191-19-056320-index.htm
2019-11-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919119056323/0001209191-19-056323-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919119057029/0001209191-19-057029-index.htm
2019-12-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919119059282/0001209191-19-059282-index.htm
2019-12-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919119059392/0001209191-19-059392-index.htm
2019-12-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919119061835/0001209191-19-061835-index.htm
2020-01-025Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919120000243/0001209191-20-000243-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919120008051/0001209191-20-008051-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919120008053/0001209191-20-008053-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919120008054/0001209191-20-008054-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919120008055/0001209191-20-008055-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919120008057/0001209191-20-008057-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919120008486/0001209191-20-008486-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919120008493/0001209191-20-008493-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919120008508/0001209191-20-008508-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919120008520/0001209191-20-008520-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919120008522/0001209191-20-008522-index.htm
2020-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919120011529/0001209191-20-011529-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919120012518/0001209191-20-012518-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919120012525/0001209191-20-012525-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919120012530/0001209191-20-012530-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919120012541/0001209191-20-012541-index.htm
2020-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919120014562/0001209191-20-014562-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919120028588/0001209191-20-028588-index.htm
2020-05-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919120030124/0001209191-20-030124-index.htm
2020-05-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919120030125/0001209191-20-030125-index.htm
2020-05-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919120030126/0001209191-20-030126-index.htm
2020-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919120031023/0001209191-20-031023-index.htm
2020-06-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919120035891/0001209191-20-035891-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919120035892/0001209191-20-035892-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919120039258/0001209191-20-039258-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919120039260/0001209191-20-039260-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919120039261/0001209191-20-039261-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919120039262/0001209191-20-039262-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919120039264/0001209191-20-039264-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919120039265/0001209191-20-039265-index.htm
2020-08-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1337553/000120919120047189/0001209191-20-047189-index.htm
2019-02-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000162828019001858/0001628280-19-001858-index.htm
2019-03-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1337553/000162828019002369/0001628280-19-002369-index.htm
2019-04-10DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1337553/000162828019004113/0001628280-19-004113-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000162828019006062/0001628280-19-006062-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1337553/000162828019006143/0001628280-19-006143-index.htm
2019-05-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000162828019007149/0001628280-19-007149-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000162828019010281/0001628280-19-010281-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1337553/000162828019010318/0001628280-19-010318-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000162828019013478/0001628280-19-013478-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1337553/000162828019013540/0001628280-19-013540-index.htm
2020-02-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000162828020001886/0001628280-20-001886-index.htm
2020-02-2410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1337553/000162828020002027/0001628280-20-002027-index.htm
2020-04-24DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1337553/000162828020005433/0001628280-20-005433-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000162828020006680/0001628280-20-006680-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1337553/000162828020006934/0001628280-20-006934-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000162828020011982/0001628280-20-011982-index.htm
2020-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1337553/000162828020012056/0001628280-20-012056-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1337553/000162828020015730/0001628280-20-015730-index.htm
2020-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1337553/000162828020015829/0001628280-20-015829-index.htm

Aerie Pharmaceuticals, Inc (AERI) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aerie Pharmaceuticals, Inc (AERI). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 211%
Institutional Ownership: 10926%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-08-12Foresite Capital Management II, LLC10% Share HolderBuy189,555.0024.434,630,828.651,060,000.00https://www.sec.gov/Archives/edgar/data/1337553/000120919119046012/0001209191-19-046012-index.htm
2019-08-13Foresite Capital Management II, LLC10% Share HolderBuy71,097.0024.921,771,737.241,131,097.00https://www.sec.gov/Archives/edgar/data/1337553/000120919119046012/0001209191-19-046012-index.htm
2020-02-27Foresite Capital Management II, LLC10% Share HolderSell271,767.0017.074,639,062.691,229,633.00https://www.sec.gov/Archives/edgar/data/1337553/000120919120014562/0001209191-20-014562-index.htm
2019-08-13Foresite Capital Management II, LLC10% Share HolderBuy178,903.0025.524,565,604.561,310,000.00https://www.sec.gov/Archives/edgar/data/1337553/000120919119046012/0001209191-19-046012-index.htm
2020-02-27Foresite Capital Management II, LLC10% Share HolderSell302,776.0017.075,168,386.321,369,938.00https://www.sec.gov/Archives/edgar/data/1337553/000120919120014562/0001209191-20-014562-index.htm
2019-09-04Foresite Capital Management II, LLC10% Share HolderBuy90,900.0018.481,679,832.001,400,900.00https://www.sec.gov/Archives/edgar/data/1337553/000120919119048830/0001209191-19-048830-index.htm
2020-05-08Gerald D. CagleDirectorSell5,000.0015.2776,350.0016,550.00https://www.sec.gov/Archives/edgar/data/1337553/000120919120028588/0001209191-20-028588-index.htm
2019-05-23DAVID W GRYSKADirectorBuy1,750.001,750.00https://www.sec.gov/Archives/edgar/data/1337553/000120919119032432/0001209191-19-032432-index.htm
2019-05-16VICENTE JR ANIDOChief Executive OfficerBuy32,171.00175,526.00https://www.sec.gov/Archives/edgar/data/1337553/000120919119031037/0001209191-19-031037-index.htm
2020-06-11Gerald D. CagleDirectorBuy1,750.0018,300.00https://www.sec.gov/Archives/edgar/data/1337553/000120919120039265/0001209191-20-039265-index.htm
2020-02-27Foresite Capital Management II, LLC10% Share HolderSell425,457.0017.077,262,550.991,925,020.00https://www.sec.gov/Archives/edgar/data/1337553/000120919120014562/0001209191-20-014562-index.htm
2019-09-09VICENTE JR ANIDOChief Executive OfficerBuy24,250.0018.93459,052.50195,631.00https://www.sec.gov/Archives/edgar/data/1337553/000120919119048930/0001209191-19-048930-index.htm
2019-09-09VICENTE JR ANIDOChief Executive OfficerBuy2,000.0019.9539,900.00197,631.00https://www.sec.gov/Archives/edgar/data/1337553/000120919119048930/0001209191-19-048930-index.htm
2019-08-14Foresite Capital Management II, LLC10% Share HolderBuy100,000.0023.732,373,000.002,050,477.00https://www.sec.gov/Archives/edgar/data/1337553/000120919119046012/0001209191-19-046012-index.htm
2019-08-16Foresite Capital Management II, LLC10% Share HolderBuy100,000.0024.232,423,000.002,150,477.00https://www.sec.gov/Archives/edgar/data/1337553/000120919119046913/0001209191-19-046913-index.htm
2019-08-19Foresite Capital Management II, LLC10% Share HolderBuy3,847.0023.3489,788.982,154,324.00https://www.sec.gov/Archives/edgar/data/1337553/000120919119046913/0001209191-19-046913-index.htm
2019-05-23Gerald D. CagleDirectorBuy1,750.0021,550.00https://www.sec.gov/Archives/edgar/data/1337553/000120919119032411/0001209191-19-032411-index.htm
2019-12-03Casey C. KopczynskiChief Scientific OfficerBuy117,000.000.4147,385.00218,511.00https://www.sec.gov/Archives/edgar/data/1337553/000120919119059282/0001209191-19-059282-index.htm
2019-08-20Foresite Capital Management II, LLC10% Share HolderBuy50,000.0023.211,160,500.002,204,324.00https://www.sec.gov/Archives/edgar/data/1337553/000120919119046913/0001209191-19-046913-index.htm
2019-08-21Foresite Capital Management II, LLC10% Share HolderBuy1,153.0023.2526,807.252,205,477.00https://www.sec.gov/Archives/edgar/data/1337553/000120919119047387/0001209191-19-047387-index.htm
2019-08-22Foresite Capital Management II, LLC10% Share HolderBuy6,700.0023.68158,656.002,212,177.00https://www.sec.gov/Archives/edgar/data/1337553/000120919119047387/0001209191-19-047387-index.htm
2019-08-23Foresite Capital Management II, LLC10% Share HolderBuy38,300.0023.42896,986.002,250,477.00https://www.sec.gov/Archives/edgar/data/1337553/000120919119047387/0001209191-19-047387-index.htm
2020-02-06VICENTE JR ANIDOChief Executive OfficerBuy28,000.00225,631.00https://www.sec.gov/Archives/edgar/data/1337553/000120919120008053/0001209191-20-008053-index.htm
2019-08-30Foresite Capital Management II, LLC10% Share HolderBuy25,000.0021.36534,000.002,275,477.00https://www.sec.gov/Archives/edgar/data/1337553/000120919119048394/0001209191-19-048394-index.htm
2020-02-06Casey C. KopczynskiChief Scientific OfficerBuy10,000.00228,511.00https://www.sec.gov/Archives/edgar/data/1337553/000120919120008057/0001209191-20-008057-index.htm
2019-09-03Foresite Capital Management II, LLC10% Share HolderBuy34,900.0020.54716,846.002,310,377.00https://www.sec.gov/Archives/edgar/data/1337553/000120919119048394/0001209191-19-048394-index.htm
2019-09-03Foresite Capital Management II, LLC10% Share HolderBuy15,100.0021.45323,895.002,325,477.00https://www.sec.gov/Archives/edgar/data/1337553/000120919119048394/0001209191-19-048394-index.htm
2019-09-04Foresite Capital Management II, LLC10% Share HolderBuy9,300.0018.48171,864.002,334,777.00https://www.sec.gov/Archives/edgar/data/1337553/000120919119048830/0001209191-19-048830-index.htm
2019-09-05Foresite Capital Management II, LLC10% Share HolderBuy15,700.0018.42289,194.002,350,477.00https://www.sec.gov/Archives/edgar/data/1337553/000120919119048830/0001209191-19-048830-index.htm
2019-11-11David HollanderChief R&D OfficerBuy25,000.0025,000.00https://www.sec.gov/Archives/edgar/data/1337553/000120919119056323/0001209191-19-056323-index.htm
2019-02-07John LaRoccaGeneral CounselBuy7,000.0025,000.00https://www.sec.gov/Archives/edgar/data/1337553/000120919119009022/0001209191-19-009022-index.htm
2019-08-14John LaRoccaGeneral CounselBuy8,000.0031,458.00https://www.sec.gov/Archives/edgar/data/1337553/000120919119046288/0001209191-19-046288-index.htm
2019-05-16RICHARD J RUBINOChief Financial OfficerBuy13,559.00336,728.00https://www.sec.gov/Archives/edgar/data/1337553/000120919119031039/0001209191-19-031039-index.htm
2019-09-09RICHARD J RUBINOChief Financial OfficerBuy5,040.0019.93100,447.20339,446.00https://www.sec.gov/Archives/edgar/data/1337553/000120919119048931/0001209191-19-048931-index.htm
2020-02-06John LaRoccaGeneral CounselBuy3,500.0034,958.00https://www.sec.gov/Archives/edgar/data/1337553/000120919120008054/0001209191-20-008054-index.htm
2020-06-11DAVID W GRYSKADirectorBuy1,750.003,500.00https://www.sec.gov/Archives/edgar/data/1337553/000120919120039261/0001209191-20-039261-index.htm
2020-02-06RICHARD J RUBINOChief Financial OfficerBuy11,750.00351,196.00https://www.sec.gov/Archives/edgar/data/1337553/000120919120008055/0001209191-20-008055-index.htm
2020-05-18MURRAY A GOLDBERGDirectorBuy28,000.003.1588,200.0036,050.00https://www.sec.gov/Archives/edgar/data/1337553/000120919120031023/0001209191-20-031023-index.htm
2019-05-23Julie McHughDirectorBuy1,750.006,350.00https://www.sec.gov/Archives/edgar/data/1337553/000120919119032437/0001209191-19-032437-index.htm
2019-05-23Richard CroarkinDirectorBuy1,750.006,350.00https://www.sec.gov/Archives/edgar/data/1337553/000120919119032414/0001209191-19-032414-index.htm
2019-05-23Toit Michael duDirectorBuy1,750.006,350.00https://www.sec.gov/Archives/edgar/data/1337553/000120919119032416/0001209191-19-032416-index.htm
2019-05-16THOMAS A MITROPresident and COOBuy13,559.0072,194.00https://www.sec.gov/Archives/edgar/data/1337553/000120919119031043/0001209191-19-031043-index.htm
2019-05-23BENJAMIN F III MCGRAWDirectorBuy1,750.008,050.00https://www.sec.gov/Archives/edgar/data/1337553/000120919119032435/0001209191-19-032435-index.htm
2019-05-23MURRAY A GOLDBERGDirectorBuy1,750.008,050.00https://www.sec.gov/Archives/edgar/data/1337553/000120919119032589/0001209191-19-032589-index.htm
2020-06-11Julie McHughDirectorBuy1,750.008,100.00https://www.sec.gov/Archives/edgar/data/1337553/000120919120039258/0001209191-20-039258-index.htm
2020-06-11Richard CroarkinDirectorBuy1,750.008,100.00https://www.sec.gov/Archives/edgar/data/1337553/000120919120039264/0001209191-20-039264-index.htm
2020-06-11Toit Michael duDirectorBuy1,750.008,100.00https://www.sec.gov/Archives/edgar/data/1337553/000120919120039262/0001209191-20-039262-index.htm
2020-02-06THOMAS A MITROPresident and COOBuy14,000.0083,849.00https://www.sec.gov/Archives/edgar/data/1337553/000120919120008051/0001209191-20-008051-index.htm
2020-06-11BENJAMIN F III MCGRAWDirectorBuy1,750.009,800.00https://www.sec.gov/Archives/edgar/data/1337553/000120919120039260/0001209191-20-039260-index.htm